Liron Levin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Liron Levin has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
- Assaf Rudich
Department of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
3 shared publications Gil Sorek
Ben-Gurion University of the Negev Department of Life Sciences Beer-Sheva 8410501
3 shared publications- Alex Braiman
Department of Microbiology, Immunology, Genetics, Ben Gurion University of the Negev, Beer-Sheva 8410501, Israel
2 shared publications - Anton Osyntsov
Surgery B Department, Soroka Medical Center, Beer-Sheva 8410101, Israel
2 shared publications - Ariel Weiner
Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, Israel
2 shared publications - Dan Bar-Yaacov
The Shraga Segal Department of Microbiology, Immunology, and Genetics, Ben-Gurion University of the Negev
2 shared publications
Latest Publications
- Open Access
- 20 November 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (22) , 10471
IL-1β Inhibition Is Associated with Reduced Tumor Growth and Changes in Anti-Tumor Immunity and the Colonic Microbiome
Colorectal cancer (CRC) is a leading cause of cancer mortality worldwide. Interleukin-1β (IL-1β) is a pro-inflammatory cytokine upregulated in many tumors, including CRC. In the tumor microenvironment (TME) it promotes angiogenesis, immunosuppression, and resistance to chemotherapy. We aimed to elucidate the correlation between TME IL-1β and colon microbiotic changes during CRC progression and approach inhibition of IL-1β in combination with standard chemotherapy as a therapeutic strategy. Using an orthotopic mouse model of CRC, we compared tumor growth, metastatic spread, immune infiltration and microbiome composition in control and IL-1β knockout mice. We studied the effects of IL-1β neutralization in combination with FOLFOX chemotherapy on CRC progression. IL-1β promotes CRC progression by enhancing pro-inflammatory signaling, associated with recruiting myeloid cells and microbiome dysbiosis. Its deficiency delayed tumor growth and reduced metastasis that was accompanied by increased infiltration of antigen-presenting cells and changes in gut microbiota. FOLFOX chemotherapy exacerbated systemic and local inflammation, facilitating liver metastasis, where the addition of anti-IL-1β antibodies significantly reduced FOLFOX-induced inflammation and enhanced anti-tumor immunity. IL-1β from the TME links microbiome dysbiosis, tumor-promoting inflammation and poor chemotherapy outcomes in CRC. Combining IL-1β inhibition with standard FOLFOX chemotherapy represents a promising therapeutic approach to CRC treatment.
- 20 November 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (22) , 10471
Open AccessIL-1β Inhibition Is Associated with Reduced Tumor Growth and Changes in Anti-Tumor Immunity and the Colonic Microbiome
Colorectal cancer (CRC) is a leading cause of cancer mortality worldwide. Interleukin-1β (IL-1β) is a pro-inflammatory cytokine upregulated in many tumors, including CRC. In the tumor microenvironment (TME) it promotes angiogenesis, immunosuppression, and resistance to chemotherapy. We aimed to elucidate the correlation between TME IL-1β and colon microbiotic changes during CRC progression and approach inhibition of IL-1β in combination with standard chemotherapy as a therapeutic strategy. Using an orthotopic mouse model of CRC, we compared tumor growth, metastatic spread, immune infiltration and microbiome composition in control and IL-1β knockout mice. We studied the effects of IL-1β neutralization in combination with FOLFOX chemotherapy on CRC progression. IL-1β promotes CRC progression by enhancing pro-inflammatory signaling, associated with recruiting myeloid cells and microbiome dysbiosis. Its deficiency delayed tumor growth and reduced metastasis that was accompanied by increased infiltration of antigen-presenting cells and changes in gut microbiota. FOLFOX chemotherapy exacerbated systemic and local inflammation, facilitating liver metastasis, where the addition of anti-IL-1β antibodies significantly reduced FOLFOX-induced inflammation and enhanced anti-tumor immunity. IL-1β from the TME links microbiome dysbiosis, tumor-promoting inflammation and poor chemotherapy outcomes in CRC. Combining IL-1β inhibition with standard FOLFOX chemotherapy represents a promising therapeutic approach to CRC treatment.
- Open Access
- 23 September 2026
- Published by MDPI AG in Preprints.org
Inhibition of IL-1β in Colon Cancer Microenvironment Declines Tumor Growth by Regulation of Anti-Tumor Immunity and Colon Microbiome
(1) Background: Colorectal cancer (CRC) is a leading cause of cancer mortality worldwide. The tumor microenvironment (TME) is a key driver of disease progression, shaping both pro- and anti-tumor immune responses. Interleukin-1β (IL-1β) is a pleiotropic pro-inflammatory cytokine that participates in both homeostatic and pathological conditions. It has been shown to be upregulated in many tumors, including CRC, where it promotes angiogenesis, immunosuppression, and resistance to chemotherapy. (2) Objective: Elucidate the correlation between TME IL-1β and colon microbiotic changes during CRC progression and approach inhibition of IL-1β as a therapeutic strategy in combination with chemotherapy. (3) Design: Using an orthotopic mouse model of CRC, we compared tumor growth, metastatic spread, immune infiltration and microbiome composition in control and IL-1β knockout mice. In addition, we studied the effects of IL-1β neutralization alone or in combination with FOLFOX chemotherapy on CRC prognosis. (4) Results: IL-1β promoted CRC progression by enhancing pro-inflammatory signalling, recruiting immunosuppressive myeloid cells, and driving microbiome dysbiosis. In contrast, IL-1β deficiency increased antigen-presenting myeloid cells and CD8+ T-cell infiltration, leading to delayed tumor growth and reduced metastasis. FOLFOX chemotherapy alone exacerbated systemic and local inflammation, facilitating liver metastasis. Strikingly, the addition of IL-1β blockade abrogated FOLFOX-induced inflammation, enhanced anti-tumor immunity, and prevented metastatic spread. (5) Conclusions: IL-1β from the TME links microbiome dysbiosis, tumor-promoting inflammation and poor chemotherapy outcomes in CRC. Combining IL-1β inhibition with standard FOLFOX chemotherapy represents a promising therapeutic approach to improve prognosis in CRC patients.
- 23 September 2026
- Published by MDPI AG in Preprints.org
Open AccessInhibition of IL-1β in Colon Cancer Microenvironment Declines Tumor Growth by Regulation of Anti-Tumor Immunity and Colon Microbiome
(1) Background: Colorectal cancer (CRC) is a leading cause of cancer mortality worldwide. The tumor microenvironment (TME) is a key driver of disease progression, shaping both pro- and anti-tumor immune responses. Interleukin-1β (IL-1β) is a pleiotropic pro-inflammatory cytokine that participates in both homeostatic and pathological conditions. It has been shown to be upregulated in many tumors, including CRC, where it promotes angiogenesis, immunosuppression, and resistance to chemotherapy. (2) Objective: Elucidate the correlation between TME IL-1β and colon microbiotic changes during CRC progression and approach inhibition of IL-1β as a therapeutic strategy in combination with chemotherapy. (3) Design: Using an orthotopic mouse model of CRC, we compared tumor growth, metastatic spread, immune infiltration and microbiome composition in control and IL-1β knockout mice. In addition, we studied the effects of IL-1β neutralization alone or in combination with FOLFOX chemotherapy on CRC prognosis. (4) Results: IL-1β promoted CRC progression by enhancing pro-inflammatory signalling, recruiting immunosuppressive myeloid cells, and driving microbiome dysbiosis. In contrast, IL-1β deficiency increased antigen-presenting myeloid cells and CD8+ T-cell infiltration, leading to delayed tumor growth and reduced metastasis. FOLFOX chemotherapy alone exacerbated systemic and local inflammation, facilitating liver metastasis. Strikingly, the addition of IL-1β blockade abrogated FOLFOX-induced inflammation, enhanced anti-tumor immunity, and prevented metastatic spread. (5) Conclusions: IL-1β from the TME links microbiome dysbiosis, tumor-promoting inflammation and poor chemotherapy outcomes in CRC. Combining IL-1β inhibition with standard FOLFOX chemotherapy represents a promising therapeutic approach to improve prognosis in CRC patients.
- Open Access
- 13 May 2026
- Published by American Society for Microbiology in mBio
- Vol. 17 (5) , e0055126
Landscape and dynamics of TadA-dependent RNA editing in Escherichia coli reveal a role in nutrient-rich growth
Adenosine-to-inosine (A-to-I) mRNA editing alters genetic information post-transcriptionally and can impact protein sequence and function, yet its regulation in bacteria remains unclear. Here, we profiled A-to-I editing in Escherichia coli across nutrient-rich Luria-Bertani (LB) and minimal M9 media and different growth phases. Our analysis expanded the repertoire of TadA-dependent A-to-I edited mRNAs to 27, including 12 novel sites, and revealed that editing levels were dynamic and markedly increased at the stationary phase in LB but not in M9. Editing levels were independent of mRNA expression yet correlated with tRNA-Arg2 downregulation, and overexpressing tRNA-Arg2 reduced mRNA editing, demonstrating substrate competition for TadA, the sole bacterial tRNA adenosine deaminase. Mutants with TadA-deficient editing or reduced tRNA-Arg2 expression displayed similar LB-specific growth defects. Moreover, tRNA-Arg2 expression, tRNA-Arg2-dependent codon usage, and tRNA-Arg2 editing were all elevated in LB compared to M9. These findings establish regulatory principles for bacterial RNA editing, implicate tRNA editing in nutrient-responsive fitness, and provide a framework to explore the physiological roles of mRNA editing. IMPORTANCE: Adenosine-to-inosine (A-to-I) mRNA editing is a recently discovered post-transcriptional mechanism in bacteria, yet its regulation and physiological roles remain poorly understood. In this study, we expand the catalog of TadA-dependent mRNA editing events in Escherichia coli and identify key regulatory factors influencing editing levels, including nutrient availability, growth phase, and tRNA-Arg2 expression. Linking altered tRNA-Arg2 levels and editing to growth defects specifically in rich medium further demonstrates that tRNA editing contributes to nutrient-responsive fitness. Together, these findings establish a framework to explore bacterial RNA editing as a regulated process with potential implications for environmental adaptation and cellular function.
- 13 May 2026
- Published by American Society for Microbiology in mBio
- Vol. 17 (5) , e0055126
Open AccessLandscape and dynamics of TadA-dependent RNA editing in Escherichia coli reveal a role in nutrient-rich growth
Adenosine-to-inosine (A-to-I) mRNA editing alters genetic information post-transcriptionally and can impact protein sequence and function, yet its regulation in bacteria remains unclear. Here, we profiled A-to-I editing in Escherichia coli across nutrient-rich Luria-Bertani (LB) and minimal M9 media and different growth phases. Our analysis expanded the repertoire of TadA-dependent A-to-I edited mRNAs to 27, including 12 novel sites, and revealed that editing levels were dynamic and markedly increased at the stationary phase in LB but not in M9. Editing levels were independent of mRNA expression yet correlated with tRNA-Arg2 downregulation, and overexpressing tRNA-Arg2 reduced mRNA editing, demonstrating substrate competition for TadA, the sole bacterial tRNA adenosine deaminase. Mutants with TadA-deficient editing or reduced tRNA-Arg2 expression displayed similar LB-specific growth defects. Moreover, tRNA-Arg2 expression, tRNA-Arg2-dependent codon usage, and tRNA-Arg2 editing were all elevated in LB compared to M9. These findings establish regulatory principles for bacterial RNA editing, implicate tRNA editing in nutrient-responsive fitness, and provide a framework to explore the physiological roles of mRNA editing. IMPORTANCE: Adenosine-to-inosine (A-to-I) mRNA editing is a recently discovered post-transcriptional mechanism in bacteria, yet its regulation and physiological roles remain poorly understood. In this study, we expand the catalog of TadA-dependent mRNA editing events in Escherichia coli and identify key regulatory factors influencing editing levels, including nutrient availability, growth phase, and tRNA-Arg2 expression. Linking altered tRNA-Arg2 levels and editing to growth defects specifically in rich medium further demonstrates that tRNA editing contributes to nutrient-responsive fitness. Together, these findings establish a framework to explore bacterial RNA editing as a regulated process with potential implications for environmental adaptation and cellular function.
- Open Access
Beyond translation initiation: dual regulatory interactions with phosphorylated and non-phosphorylated LeishIF4E1
Translation initiation in eukaryotes begins with the assembly of the cap-binding eIF4F complex at the 5’ ends of mRNAs, through eIF4E. Among the six orthologs of eIF4E in Leishmania , LeishIF4E1 is intriguing, as it does not bind any Leishmania eIF4G. It is expressed in both life-forms, maintaining efficient cap-binding activity for translation initiation, unlike other LeishIF4Es. We identified two novel phosphorylation sites specifically S108, and S112, along with S203, which is conserved with the mammalian phosphorylation site. A non-phosphorylatable, tagged, mutant of LeishIF4E1 created by substituting the phosphorylated serine residues with alanine [S(108,112,203)A] was generated. The phosphorylation status did not affect the binding of LeishIF4E1 to translation initiation factors. However, the phosphorylated LeishIF4E1 interacted with proteins involved in DNA and chromatin structure, while non-phosphorylated LeishIF4E1 interacted with proteins that assist cells under stress and unfavorable conditions, particularly in gluconeogenesis. This suggests secondary regulatory roles for LeishIF4E1. RNA sequencing of the LeishIF4E1-associated transcripts revealed a tenfold reduction in transcripts binding to non-phosphorylated LeishIF4E1. GO enrichment analysis indicated distinct phosphorylation-dependent transcript specificities for each form. This study highlights the critical role of LeishIF4E1 phosphorylation in modulating the selectivity of protein interactome and transcript associations, extending the role of LeishIF4E1 beyond its well-established function in translation initiation. Author Summary: Leishmania are digenetic parasites that transition from sand fly vector to mammalian hosts, undergoing a developmental program of gene expression regulated at the level of translation. Protein synthesis is initiated by the assembly of multi-subunit complexes at the mRNA 5’ cap structure and is recruited onto the ribosomes. There are six cap-binding proteins in Leishmania denoted LeishIF4Es1-6, and five LeishIF4G candidates. Among these, the function of LeishIF4E1 is intriguing, as it does not bind any LeishIF4G paralogs, and it is highly expressed in both parasite life forms. We examined how LeishIF4E1 phosphorylation modulates its interaction with proteins and transcripts, given that eIF4E phosphorylation in higher eukaryotes is known to regulate gene expression during malignancy. We identified three phosphorylation sites (S108, S112 and S203) and mutated them to A residues [S(108,112,203)A]. The mutated genes were transfected back into parasites for expression. Using pull-down assays, we identified the interacting proteins and associated transcripts for both the phosphorylated and non-phosphorylated LeishIF4E1 forms. The phosphorylated LeishIF4E1 pulled down proteins involved in DNA and chromatin structure, while the non-phosphorylated LeishIF4E1 interacted with proteins known to assist cells during stress and unfavorable conditions, especially gluconeogenesis. The transcript specificities differed markedly in the number of transcripts bound to both forms, shedding light on the importance of LeishIF4E1 phosphorylation. Furthermore, the phosphorylated form bound more transcripts encoding enzymes related to protein phosphorylation. We also showed that phosphorylation of LeishIF4E1 did not influence the cap-binding ability, as both the forms bind the m 7 GTP cap with parallel efficiencies. Our data suggest that the different cap-binding proteins in Leishmania are responsible for different processes and have a transcript-specific effect on gene expression.
Open AccessBeyond translation initiation: dual regulatory interactions with phosphorylated and non-phosphorylated LeishIF4E1
Translation initiation in eukaryotes begins with the assembly of the cap-binding eIF4F complex at the 5’ ends of mRNAs, through eIF4E. Among the six orthologs of eIF4E in Leishmania , LeishIF4E1 is intriguing, as it does not bind any Leishmania eIF4G. It is expressed in both life-forms, maintaining efficient cap-binding activity for translation initiation, unlike other LeishIF4Es. We identified two novel phosphorylation sites specifically S108, and S112, along with S203, which is conserved with the mammalian phosphorylation site. A non-phosphorylatable, tagged, mutant of LeishIF4E1 created by substituting the phosphorylated serine residues with alanine [S(108,112,203)A] was generated. The phosphorylation status did not affect the binding of LeishIF4E1 to translation initiation factors. However, the phosphorylated LeishIF4E1 interacted with proteins involved in DNA and chromatin structure, while non-phosphorylated LeishIF4E1 interacted with proteins that assist cells under stress and unfavorable conditions, particularly in gluconeogenesis. This suggests secondary regulatory roles for LeishIF4E1. RNA sequencing of the LeishIF4E1-associated transcripts revealed a tenfold reduction in transcripts binding to non-phosphorylated LeishIF4E1. GO enrichment analysis indicated distinct phosphorylation-dependent transcript specificities for each form. This study highlights the critical role of LeishIF4E1 phosphorylation in modulating the selectivity of protein interactome and transcript associations, extending the role of LeishIF4E1 beyond its well-established function in translation initiation. Author Summary: Leishmania are digenetic parasites that transition from sand fly vector to mammalian hosts, undergoing a developmental program of gene expression regulated at the level of translation. Protein synthesis is initiated by the assembly of multi-subunit complexes at the mRNA 5’ cap structure and is recruited onto the ribosomes. There are six cap-binding proteins in Leishmania denoted LeishIF4Es1-6, and five LeishIF4G candidates. Among these, the function of LeishIF4E1 is intriguing, as it does not bind any LeishIF4G paralogs, and it is highly expressed in both parasite life forms. We examined how LeishIF4E1 phosphorylation modulates its interaction with proteins and transcripts, given that eIF4E phosphorylation in higher eukaryotes is known to regulate gene expression during malignancy. We identified three phosphorylation sites (S108, S112 and S203) and mutated them to A residues [S(108,112,203)A]. The mutated genes were transfected back into parasites for expression. Using pull-down assays, we identified the interacting proteins and associated transcripts for both the phosphorylated and non-phosphorylated LeishIF4E1 forms. The phosphorylated LeishIF4E1 pulled down proteins involved in DNA and chromatin structure, while the non-phosphorylated LeishIF4E1 interacted with proteins known to assist cells during stress and unfavorable conditions, especially gluconeogenesis. The transcript specificities differed markedly in the number of transcripts bound to both forms, shedding light on the importance of LeishIF4E1 phosphorylation. Furthermore, the phosphorylated form bound more transcripts encoding enzymes related to protein phosphorylation. We also showed that phosphorylation of LeishIF4E1 did not influence the cap-binding ability, as both the forms bind the m 7 GTP cap with parallel efficiencies. Our data suggest that the different cap-binding proteins in Leishmania are responsible for different processes and have a transcript-specific effect on gene expression.
- Open Access
- 8 July 2025
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 53 (13)
A-to-I mRNA editing recodes hundreds of genes in dozens of species and produces endogenous protein isoforms in bacteria
Adenosine-to-inosine (A-to-I) messenger RNA (mRNA) editing can affect the sequence and function of translated proteins and has been extensively investigated in eukaryotes. However, the prevalence of A-to-I mRNA editing in bacteria, its governing regulatory principles, and its biological significance are poorly understood. Here, we show that A-to-I mRNA editing occurs in hundreds of transcripts across dozens of gammaproteobacterial species, with most edits predicted to recode protein sequences. Furthermore, we reveal conserved regulatory determinants controlling editing across gammaproteobacterial species. Using Acinetobacter baylyi as a model, we show that mutating TadA, the mediating enzyme, reduces editing across all sites. Conversely, overexpressing TadA resulted in the editing of >300 transcripts, attesting to the editing potential of TadA. Notably, we show for the first time, at the protein level, that normal levels of A-to-I mRNA editing lead to wild-type bacteria expressing two protein isoforms from a single gene. Finally, we show that a TadA mutant with deficient editing activity does not grow at high temperatures, suggesting that RNA editing has a functional role in bacteria. Our work reveals that A-to-I mRNA editing in bacteria is widespread and has the potential to reshape the bacterial transcriptome and proteome.
- 8 July 2025
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 53 (13)
Open AccessA-to-I mRNA editing recodes hundreds of genes in dozens of species and produces endogenous protein isoforms in bacteria
Adenosine-to-inosine (A-to-I) messenger RNA (mRNA) editing can affect the sequence and function of translated proteins and has been extensively investigated in eukaryotes. However, the prevalence of A-to-I mRNA editing in bacteria, its governing regulatory principles, and its biological significance are poorly understood. Here, we show that A-to-I mRNA editing occurs in hundreds of transcripts across dozens of gammaproteobacterial species, with most edits predicted to recode protein sequences. Furthermore, we reveal conserved regulatory determinants controlling editing across gammaproteobacterial species. Using Acinetobacter baylyi as a model, we show that mutating TadA, the mediating enzyme, reduces editing across all sites. Conversely, overexpressing TadA resulted in the editing of >300 transcripts, attesting to the editing potential of TadA. Notably, we show for the first time, at the protein level, that normal levels of A-to-I mRNA editing lead to wild-type bacteria expressing two protein isoforms from a single gene. Finally, we show that a TadA mutant with deficient editing activity does not grow at high temperatures, suggesting that RNA editing has a functional role in bacteria. Our work reveals that A-to-I mRNA editing in bacteria is widespread and has the potential to reshape the bacterial transcriptome and proteome.
- Open Access
- 17 May 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (11) , 2593-2595.e4
CASZ1 Regulates Late Epidermal Differentiation
- 17 May 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (11) , 2593-2595.e4
Open AccessCASZ1 Regulates Late Epidermal Differentiation
- Top Cited Papers
- 15 March 2024
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 383 (6688) , eadj9223
Cryptic diversity of cellulose-degrading gut bacteria in industrialized humans
Humans, like all mammals, depend on the gut microbiome for digestion of cellulose, the main component of plant fiber. However, evidence for cellulose fermentation in the human gut is scarce. We have identified ruminococcal species in the gut microbiota of human populations that assemble functional multienzymatic cellulosome structures capable of degrading plant cell wall polysaccharides. One of these species, which is strongly associated with humans, likely originated in the ruminant gut and was subsequently transferred to the human gut, potentially during domestication where it underwent diversification and diet-related adaptation through the acquisition of genes from other gut microbes. Collectively, these species are abundant and widespread among ancient humans, hunter-gatherers, and rural populations but are rare in populations from industrialized societies thus indicating potential disappearance in response to the westernized lifestyle.
- 15 March 2024
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 383 (6688) , eadj9223
Top Cited PapersCryptic diversity of cellulose-degrading gut bacteria in industrialized humans
Humans, like all mammals, depend on the gut microbiome for digestion of cellulose, the main component of plant fiber. However, evidence for cellulose fermentation in the human gut is scarce. We have identified ruminococcal species in the gut microbiota of human populations that assemble functional multienzymatic cellulosome structures capable of degrading plant cell wall polysaccharides. One of these species, which is strongly associated with humans, likely originated in the ruminant gut and was subsequently transferred to the human gut, potentially during domestication where it underwent diversification and diet-related adaptation through the acquisition of genes from other gut microbes. Collectively, these species are abundant and widespread among ancient humans, hunter-gatherers, and rural populations but are rare in populations from industrialized societies thus indicating potential disappearance in response to the westernized lifestyle.
- Open Access
- 15 August 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (16) , 12824
The Molecular Mechanisms Employed by the Parasite Myxobolus bejeranoi (Cnidaria: Myxozoa) from Invasion through Sporulation for Successful Proliferation in Its Fish Host
Myxozoa is a unique group of obligate endoparasites in the phylum Cnidaria that can cause emerging diseases in wild and cultured fish populations. Recently, we identified a new myxozoan species, Myxobolus bejeranoi, which infects the gills of cultured tilapia while suppressing host immunity. To uncover the molecular mechanisms underlying this successful parasitic strategy, we conducted transcriptomics analysis of M. bejeranoi throughout the infection. Our results show that histones, which are essential for accelerated cell division, are highly expressed even one day after invasion. As the infection progressed, conserved parasitic genes that are known to modulate the host immune reaction in different parasitic taxa were upregulated. These genes included energy-related glycolytic enzymes, as well as calreticulin, proteases, and miRNA biogenesis proteins. Interestingly, myxozoan calreticulin formed a distinct phylogenetic clade apart from other cnidarians, suggesting a possible function in parasite pathogenesis. Sporogenesis was in its final stages 20 days post-exposure, as spore-specific markers were highly expressed. Lastly, we provide the first catalog of transcription factors in a Myxozoa species, which is minimized compared to free-living cnidarians and is dominated by homeodomain types. Overall, these molecular insights into myxozoan infection support the concept that parasitic strategies are a result of convergent evolution.
- 15 August 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (16) , 12824
Open AccessThe Molecular Mechanisms Employed by the Parasite Myxobolus bejeranoi (Cnidaria: Myxozoa) from Invasion through Sporulation for Successful Proliferation in Its Fish Host
Myxozoa is a unique group of obligate endoparasites in the phylum Cnidaria that can cause emerging diseases in wild and cultured fish populations. Recently, we identified a new myxozoan species, Myxobolus bejeranoi, which infects the gills of cultured tilapia while suppressing host immunity. To uncover the molecular mechanisms underlying this successful parasitic strategy, we conducted transcriptomics analysis of M. bejeranoi throughout the infection. Our results show that histones, which are essential for accelerated cell division, are highly expressed even one day after invasion. As the infection progressed, conserved parasitic genes that are known to modulate the host immune reaction in different parasitic taxa were upregulated. These genes included energy-related glycolytic enzymes, as well as calreticulin, proteases, and miRNA biogenesis proteins. Interestingly, myxozoan calreticulin formed a distinct phylogenetic clade apart from other cnidarians, suggesting a possible function in parasite pathogenesis. Sporogenesis was in its final stages 20 days post-exposure, as spore-specific markers were highly expressed. Lastly, we provide the first catalog of transcription factors in a Myxozoa species, which is minimized compared to free-living cnidarians and is dominated by homeodomain types. Overall, these molecular insights into myxozoan infection support the concept that parasitic strategies are a result of convergent evolution.
- Open Access
sNucConv: A bulk RNA-seq deconvolution method trained on single-nucleus RNA-seq data to estimate cell-type composition of human subcutaneous and visceral adipose tissues
Deconvolution algorithms rely on single-cell RNA-sequencing (scRNA-seq) data applied onto bulk RNA-sequencing (bulk RNA-seq) to extract information on the cell-types composition and proportions comprising a certain tissue. Adipose tissues’ cellular composition exhibits enormous plasticity in response to weight changes and high variance at different anatomical locations (depots). However, adipocytes – the functionally unique cell type of adipose tissue, are not amenable to scRNA-seq, a challenge recently met by applying single-nucleus RNA-sequencing (snRNA-seq). Here we aimed to develop a deconvolution method to estimate the cellular composition of human visceral and subcutaneous adipose tissues (hVAT and hSAT, respectively) using snRNA-seq to assess the true cell-type proportions. To correlate deconvolution-estimated cell-type proportions to true (snRNA-seq -derived) proportions, we analyzed seven hVAT and 5 hSAT samples by both bulk RNA-seq and snRNA-seq. snRNA-seq uncovered 15 distinct cell types in hVAT and 13 in hSAT. Deconvolution tools – SCDC, MuSiC, and Scaden exhibited low performance in estimating cell-type proportions (median |R|= 0.12 for estimated vs. true correlations). Notably, estimation accuracy somewhat improved by decreasing the number of cell-types groups, which nevertheless remained low (|R|sNuConv , a novel method that employs Scaden, a deep-learning tool, trained using snRNA-seq - based data corrected by i. snRNA-seq/bulk RNA-seq highly-correlated genes, ii. corrected estimated cell-type proportions based on individual cell-type regression models. Applying sNuConv on our bulk RNA-seq data resulted in cell-type proportion estimation accuracy with median R=0.93 (range:0.76–0.97) for hVAT, and median R=0.95 (range:0.92–0.98) for hSAT. The resulting model was depot-specific, reflecting depot-differences in gene expression patterns. Thus, we present sNuConv, a novel, AI-based, method to deduce the cellular landscape of hVAT and hSAT from bulk RNA-seq data, providing proof-of-concept for producing validated deconvolution algorithms for tissues un-amenable to single-cell RNA sequencing.
Open AccesssNucConv: A bulk RNA-seq deconvolution method trained on single-nucleus RNA-seq data to estimate cell-type composition of human subcutaneous and visceral adipose tissues
Deconvolution algorithms rely on single-cell RNA-sequencing (scRNA-seq) data applied onto bulk RNA-sequencing (bulk RNA-seq) to extract information on the cell-types composition and proportions comprising a certain tissue. Adipose tissues’ cellular composition exhibits enormous plasticity in response to weight changes and high variance at different anatomical locations (depots). However, adipocytes – the functionally unique cell type of adipose tissue, are not amenable to scRNA-seq, a challenge recently met by applying single-nucleus RNA-sequencing (snRNA-seq). Here we aimed to develop a deconvolution method to estimate the cellular composition of human visceral and subcutaneous adipose tissues (hVAT and hSAT, respectively) using snRNA-seq to assess the true cell-type proportions. To correlate deconvolution-estimated cell-type proportions to true (snRNA-seq -derived) proportions, we analyzed seven hVAT and 5 hSAT samples by both bulk RNA-seq and snRNA-seq. snRNA-seq uncovered 15 distinct cell types in hVAT and 13 in hSAT. Deconvolution tools – SCDC, MuSiC, and Scaden exhibited low performance in estimating cell-type proportions (median |R|= 0.12 for estimated vs. true correlations). Notably, estimation accuracy somewhat improved by decreasing the number of cell-types groups, which nevertheless remained low (|R|sNuConv , a novel method that employs Scaden, a deep-learning tool, trained using snRNA-seq - based data corrected by i. snRNA-seq/bulk RNA-seq highly-correlated genes, ii. corrected estimated cell-type proportions based on individual cell-type regression models. Applying sNuConv on our bulk RNA-seq data resulted in cell-type proportion estimation accuracy with median R=0.93 (range:0.76–0.97) for hVAT, and median R=0.95 (range:0.92–0.98) for hSAT. The resulting model was depot-specific, reflecting depot-differences in gene expression patterns. Thus, we present sNuConv, a novel, AI-based, method to deduce the cellular landscape of hVAT and hSAT from bulk RNA-seq data, providing proof-of-concept for producing validated deconvolution algorithms for tissues un-amenable to single-cell RNA sequencing.